首页> 外文期刊>AIDS Research and Human Retroviruses >Short Communication: Limited HIV Pretreatment Drug Resistance Among Adults Attending Free Antiretroviral Therapy Clinic of Pune, India
【24h】

Short Communication: Limited HIV Pretreatment Drug Resistance Among Adults Attending Free Antiretroviral Therapy Clinic of Pune, India

机译:简短交流:参加印度普纳免费抗逆转录病毒疗法诊所的成年人中,艾滋病毒有限的治疗前耐药性

获取原文
获取原文并翻译 | 示例
           

摘要

In India, the roll out of the free antiretroviral therapy (ART) program completed a decade of its initiation in 2014. The success of first-line ART is influenced by prevalence of HIV pretreatment drug resistance (PDR) in the population. In this cross-sectional study, we sought to determine the prevalence of PDR among adults attending the state-sponsored free ART clinic in Pune in western India. Fifty-two individuals eligible for ART as per national guidelines with median CD4 cell count of 253 cells/mm(3) (inter quartile range: 149-326) were recruited between January 2014 and April 2015. Population-based sequencing of partial pol gene sequences from plasma specimen revealed predominant HIV-1 subtype C infection (96.15%) and presence of single-drug resistance mutations against non-nucleoside reverse transcriptase inhibitor in two sequences. The study supports the need for periodic surveillance, when offering PDR testing at individual level is not feasible.
机译:在印度,免费抗逆转录病毒疗法(ART)计划的推出已在2014年启动十周年。一线抗逆转录病毒疗法的成功受到人群中HIV预处理药物耐药性(PDR)患病率的影响。在这项横断面研究中,我们试图确定在印度西部浦那州政府资助的免费抗逆转录病毒治疗诊所就诊的成年人中PDR的患病率。在2014年1月至2015年4月之间,招募了52名符合国家指导原则的抗CD4个人,其CD4细胞中位数为253个细胞/ mm(3)(四分位间距:149-326)。基于人群的部分pol基因测序血浆标本中的序列显示出主要的HIV-1 C型亚型感染(96.15%),并且在两个序列中均存在针对非核苷逆转录酶抑制剂的单药耐药突变。当在个人级别上提供PDR测试不可行时,该研究支持需要定期监视。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号